Amgen (AMGN) Tops Q1 EPS by 61c; offers guidance

Amgen (NASDAQ: AMGN) reported Q1 EPS of $4.90, $0.61 better than the analyst estimate of $4.29. Revenue for the quarter came in at $8.15 billion versus the consensus estimate of $8.09 billion.

GUIDANCE:

Amgen sees FY2025 EPS of $20.00-$21.20, versus the consensus of $20.63. Amgen sees FY2025 revenue of $34.3-35.7 billion, versus the consensus of $35.102 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Increasing unusual option volume: XP ACAD GFL XEL ALHC BORR BORR GPRE UNM FDXF JBHT ECO FPS CYPH UMC CARR BBY VEA CX
• Wells Fargo Starts Terawulf Inc. (WULF) at Overweight